| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Natera, Inc. (NTRA) has 14 insiders with recent SEC Form 4 filings, including 0 buys and 35 sells. NTRA is classified in the Life Sciences Tools & Services industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| Other | 2.30M | $522.23M | -100,000 | |
| Dir | 1.17M | $266.38M | - | |
| Dir | 249.4K | $56.60M | -3,150 | |
| Other | 222.7K | $50.55M | - | |
| Pres | 185.8K | $42.17M | -1,438 |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Jan 22, 2025 | Chapman Steven Leonard56 | CEO And President | Sale+OE | 78,553 | $164.97 | $12,958,585.02 | -12.8% | -15.9% | +41.3% | |
| Jan 22, 2025 | Rabinowitz Daniel48 | Sec. And Chief Legal Officer | Sale+OE | 22,039 | $164.97 | $3,635,684.56 | -4.8% | -15.9% | +41.3% | |
| Jan 8, 2025 | Rabinowitz Daniel48 | Sec. And Chief Legal Officer | Sell | 6,223 | $175.30 | $1,090,901.23 | -3.0% | -25.1% | +35.6% | |
| Jan 2, 2025 | Sheena Jonathan46 | Director, Co-founder | Sell | 5,700 | $159.50 | $909,125.62 | -0.5% | -10.8% | +42.5% | |
| Dec 23, 2024 | Fesko John | President, Chief Bus. Officer | Sell | 669 | $159.60 | $106,773.49 | -0.3% | -5.0% | +45.3% | |
| Dec 23, 2024 | Moshkevich Solomon | President, Clinicaldiagnostics | Sell | 2,428 | $159.60 | $387,511.41 | -0.7% | -5.0% | +45.3% | |
| Dec 18, 2024 | Sheena Jonathan46 | Director, Co-founder | Sell | 5,700 | $167.25 | $953,337.28 | -0.5% | -5.7% | +44.8% | |
| Dec 13, 2024 | Rabinowitz Matthew59 | Executive Chairman | Sell | 160,000 | $165.74 | $26,518,749.54 | -1.3% | -14.4% | +39.3% | |
| Dec 10, 2024 | Chapman Rowan E52 | Director | Sell | 1,767 | $170.24 | $300,808.25 | -22.2% | -20.3% | +40.1% | |
| Dec 9, 2024 | Moshkevich Solomon | President, Clinicaldiagnostics | Sale+OE | 4,858 | $166.59 | $809,312.19 | -4.1% | -21.0% | +40.4% |